Atlas Trials

A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness

Clinical trial NCT05819112 · TERMINATED

Trial details

NCT number
NCT05819112
Sponsor
Sanofi
Status
TERMINATED
Study type
OBSERVATIONAL
Venous Thromboembolism
Start date
2023-04-25
Primary completion
2023-12-15
Enrollment
14799

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.